ARCA Hero Image
Investor Relations

Press Releases

[+view all]
02.20.2019
ARCA BIOPHARMA ANNOUNCES FDA AGREEMENT FOR A SINGLE PHASE 3 CLINICAL TRIAL TO SUPPORT APPROVAL FOR THE FIRST GENETICALLY-TARGETED CARDIOVASCULAR DRUG
12.20.2018
ARCA BIOPHARMA UPDATES SPECIAL PROTOCOL ASSESSMENT REQUEST TO FDA FOR GENCARO PHASE 3 ATRIAL FIBRILLATION CLINICAL TRIAL
11.14.2018
ARCA BIOPHARMA ANNOUNCES THIRD QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Investor Relations

Press Releases

[+view all]
02.20.2019
ARCA BIOPHARMA ANNOUNCES FDA AGREEMENT FOR A SINGLE PHASE 3 CLINICAL TRIAL TO SUPPORT APPROVAL FOR THE FIRST GENETICALLY-TARGETED CARDIOVASCULAR DRUG
12.20.2018
ARCA BIOPHARMA UPDATES SPECIAL PROTOCOL ASSESSMENT REQUEST TO FDA FOR GENCARO PHASE 3 ATRIAL FIBRILLATION CLINICAL TRIAL
11.14.2018
ARCA BIOPHARMA ANNOUNCES THIRD QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
ir-presentations
Presentations
[GO]
ir-reports
Annual Financial Reports
[GO]
ir-filings
SEC Filings
[GO]
ir-faq
Frequently Asked Questions
[GO]
ir-corp-gov

Corporate Governance

Committee Charters

PDF Icon
Audit Committee
PDF Icon
Compensation Committee
PDF Icon
Nominating & Governance Committee

Governance Documents

PDF Icon
Board of Directors Corporate Governance Principles
PDF Icon
ARCA biopharma, Inc. Code of Business Conduct and Ethics
PDF Icon
ARCA biopharma, Inc. Complaint and Investigation Policy and Procedure
PDF Icon
Contact the Board
Chairperson
Member
Chairperson
Member
Audit Committee
Compensation Committee
Nominating & Governance Committee
Raymond L. Woosley, M.D., Ph.D.
Member
Chairperson
Linda Grais, M.D.
Member
Chairperson
Robert E. Conway
Chairperson
Member
Dan Mitchell
Member
Member
Anders Hove, M.D.
Member